Precision Medicine: Structuring Collaborations and Avoiding Fraud and Abuse Pitfalls
Navigating Healthcare Regulatory Issues Common in Precision Medicine Arrangements Among Hospitals, Health Systems, and Clinical Laboratories
A live 90-minute CLE webinar with interactive Q&A
This CLE webinar will offer guidance to healthcare counsel on precision medicine and the associated collaborations. The panel will examine the fair market value (FMV) requirements as well as the fraud and abuse risks. The panel will offer guidance on how to ensure compliance and avoid the challenges of precision medicine.
- Introduction and overview of collaborative arrangements
- Fraud and abuse considerations
- Stark Law
- Medicare Beneficiary Inducement Statute
- State law equivalents
- Other healthcare regulatory considerations
- Federal and state privacy and security laws
- Anti-markup laws
- Practical guidance and take-aways
The panel will review these and other key issues:
- What are the FMV requirements that must be met with precision medicine collaborations?
- What steps can counsel take to avoid common FMV pitfalls?
- What are the risks for Medicare compliance with precision medicine collaborations?
- What other legal issues should counsel evaluate when structuring precision medicine collaborations?
Carolyn V. Metnick
McDermott Will & Emery
Ms. Metnick concentrates her practice on transactional and business issues affecting healthcare providers. She... | Read More
Ms. Metnick concentrates her practice on transactional and business issues affecting healthcare providers. She routinely guides her healthcare clients through various transactions including joint ventures, M&As and reorganizations. Ms. Metnick counsels her clients on governance matters, regulatory issues, and federal fraud and abuse laws. She also counsels her clients on HIPAA compliance, healthcare technology (mData), and disputes and litigation with an emphasis in contract law, covenants not to compete, and business torts.Close
Stacey L. Callaghan
McDermott Will & Emery
Ms. Callaghan counsels healthcare entities, healthcare technology companies, data companies, and private equity... | Read More
Ms. Callaghan counsels healthcare entities, healthcare technology companies, data companies, and private equity entities as they navigate transactional, regulatory, and compliance issues. She focuses on assisting clients on matters including data privacy and protection requirements under HIPAA and other privacy laws, data breach investigations and compliance, and data sharing, licensing, and de-identification arrangements. Ms. Callaghan also assists clients in developing telemedicine strategies and documenting agreements given the evolving digital health regulatory landscape.Close
Buy Live Webinar
Includes Early Discount Savings of $50 (through 07/24/20)
Buy Live Webinar & Recording
Includes special savings of $250 (through 07/24/20)
Live Webinar & Download
Live Webinar & DVD
$344 + $24.45 S&H